Cupertino, CA · Health Care · Form D filed Sep 28, 2026
Pace Pharmaceuticals, Inc. raised $50K
Pace Pharmaceuticals, Inc. is a biotechnology company based in Cupertino, California. In a Form D filed with the SEC on September 28, 2026, it reported raising $50,000 from 1 investor as part of an offering of indefinite size. The first sale in the offering took place on September 18, 2026.
Pace Pharmaceuticals integrates AI and laboratory robotics to develop new medicines for neurological disease. Explore our compounds and research.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Open-ended round. The offering has no stated size limit.
- Rule 506(c) offering. The company may advertise this round publicly; buyers must be verified accredited investors.
$50K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 28, 2026 | $50K | Open | 1 |
Lead score
44 out of 100
filed recently first raise ever still raising website found young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- pacepharmaceuticals.com
- Amount raised
- $50,000
- Offering size
- Indefinite
- Investors so far
- 1
- Minimum investment
- $50,000
- First sale
- September 18, 2026
- Securities offered
- Other
- Exemption claimed
- Rule 506(c)
- Industry
- Biotechnology
- Headquarters
- Cupertino, California
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $50,000 | Indefinite | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 28, 2026 · Health Care funding in California · September 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
Tempest Therapeutics, Inc.
Brisbane, CA · filed Oct 145th Form D since 2013
Renue Life Sciences, Inc.
San Carlos, CA · filed Oct 14First Form DStill raising
iPill Inc.
Rowland Heights, CA · filed Oct 132nd Form D since 2025Still raising
White Eagle Sonic Technologies, Inc.
Santa Clara, CA · filed Oct 135th Form D since 2012Still raising
Digestive Disease Center, L.P.
Laguna Hills, CA · filed Oct 83rd Form D since 2022
Lionheart Health, Inc.
Huntington Beach, CA · filed Oct 7First Form DStill raising